- Home
- BPMC vs MAT Comparison
BPMC vs MAT Comparison
Compare BPMC & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- MAT
- Stock Information
- Founded
- BPMC 2008
- MAT 1945
- Country
- BPMC United States
- MAT United States
- Employees
- BPMC N/A
- MAT N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- MAT Recreational Games/Products/Toys
- Sector
- BPMC Health Care
- MAT Consumer Discretionary
- Exchange
- BPMC Nasdaq
- MAT Nasdaq
- Market Cap
- BPMC 5.8B
- MAT 6.2B
- IPO Year
- BPMC 2015
- MAT N/A
- Fundamental
- Price
- BPMC $128.35
- MAT $20.42
- Analyst Decision
- BPMC Buy
- MAT Strong Buy
- Analyst Count
- BPMC 20
- MAT 9
- Target Price
- BPMC $127.82
- MAT $24.56
- AVG Volume (30 Days)
- BPMC 3.6M
- MAT 2.8M
- Earning Date
- BPMC 07-31-2025
- MAT 07-23-2025
- Dividend Yield
- BPMC N/A
- MAT N/A
- EPS Growth
- BPMC N/A
- MAT 90.10
- EPS
- BPMC N/A
- MAT 1.57
- Revenue
- BPMC $562,121,000.00
- MAT $5,396,667,000.00
- Revenue This Year
- BPMC $44.46
- MAT $2.57
- Revenue Next Year
- BPMC $32.78
- MAT $1.90
- P/E Ratio
- BPMC N/A
- MAT $13.02
- Revenue Growth
- BPMC 99.19
- MAT N/A
- 52 Week Low
- BPMC $73.04
- MAT $13.95
- 52 Week High
- BPMC $128.52
- MAT $22.07
- Technical
- Relative Strength Index (RSI)
- BPMC 74.59
- MAT 65.26
- Support Level
- BPMC $128.06
- MAT $19.46
- Resistance Level
- BPMC $128.52
- MAT $20.60
- Average True Range (ATR)
- BPMC 0.28
- MAT 0.48
- MACD
- BPMC -1.18
- MAT 0.10
- Stochastic Oscillator
- BPMC 74.44
- MAT 90.67
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.